Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Bile Duct Carcinoma · Gall Bladder Cancer · Biliary Tract Cancer · Cholangiocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Contact: Study coordinator (Zhen Liu, MD) · liuzhen@cancer.ac.cn · 86-571-87235407
Contact: Principal Investigator (Jianzhen Shan, MD)

Study leads

Tingbo Liang, MD
Principal Investigator
Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery

Intrahepatic Bile Duct Cancer · Intrahepatic Cholangiocarcinoma (Icc) · Intrahepatic Bile Duct Carcinoma

Abroad (travel likely)RecruitingPHASE2

Rotterdam, Netherlands

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Cholangiocarcinoma · Hilar Cholangiocarcinoma · Bile Duct Cancer

Abroad (travel likely)RecruitingPHASE2

Jinan, China

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Bile Duct Cancer · Cholangiocarcinoma · Cholangiocarcinoma Non-resectable

Abroad (travel likely)RecruitingPHASE2

Boston, United States

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Bile Duct Cancer · Gall Bladder Cancer · Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gainesville, United States